Arkolith/Insider Trading/CDAK/Form 4

Bain Linda

Chief Financial OfficerCodiak BioSciences, Inc. (CDAK) · full profile →Form 4 · filed Feb 21, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 17, 2023Sell(S)3K$0.59$2K13K
Feb 16, 2023Option exercise(M)8K——16K
Aug 17, 2022Sell(S)2K$2.21$5K8K
Aug 16, 2022Option exercise(M)8K——11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 16, 2023Option exercise(M)8K—$015K
Aug 16, 2022Option exercise(M)8K—$023K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-005697) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML